Relay Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $677 | $7,679 | $0 | $0 |
Gross Profit | -325 | 7,679 | -7,244 | -1,367 |
EBITDA | -76,847 | -84,869 | -83,645 | -95,002 |
EBIT | -86,077 | -84,979 | -96,369 | |
Net Income | -70,375 | -77,065 | -76,004 | -88,105 |
Net Change In Cash | 677 | 7,679 | 0 | 0 |
Free Cash Flow | -55,287 | -73,594 | -57,868 | -75,310 |
Cash | 113,941 | 93,542 | 124,287 | 152,357 |
Basic Shares | 171,264 | 169,233 | 167,337 | 140,229 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $10,007 | $25,546 | $1,381 | $3,029 |
Gross Profit | -305,434 | 25,546 | -241,624 | -166,359 |
EBITDA | -380,210 | -374,153 | -306,822 | -222,182 |
EBIT | -385,674 | -379,422 | -310,952 | -226,107 |
Net Income | -337,708 | -341,973 | -290,509 | -363,872 |
Net Change In Cash | 10,007 | 25,546 | 1,381 | 3,029 |
Cost of Revenue | -128,325 | -165,827 | ||
Free Cash Flow | -251,125 | -304,442 | -238,552 | -77,877 |
Cash | 124,287 | 143,736 | 151,794 | 280,119 |
Basic Shares | 142,867 | 122,576 | 112,233 | 95,136 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.41 |
2025-03-31 | -$0.45 |
2024-12-31 | -$0.45 |
